Search - tctmd.com

Displaying 421 - 440 of 600

Sort: Relevancy | Date

News Daily News

‘Accelerated Atherosclerosis’ Not Uncommon in Arteries of Young People

Caitlin E. Cox

November 15, 2018

News Conference News AHA 2018

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

Michael O'Riordan

November 15, 2018

News Conference News VIVA 2018

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

L.A. McKeown

November 15, 2018

News Conference News AHA 2018

Sit Less, Move More: New Physical Activity Guidelines Stress Movement at All Ages

Michael O'Riordan

November 12, 2018

News Conference News AHA 2018

New Cholesterol Guidelines Make Room for Non-Statin Therapy and CAC Screening

Michael O'Riordan

November 10, 2018

News Daily News

ODYSSEY Outcomes Published as New Cholesterol Guidelines Loom

Michael O'Riordan

November 07, 2018

News Daily News

Statins Provide No Clinical Benefit When Coronary Calcium Is Zero, Study Shows

Michael O'Riordan

November 06, 2018

News Daily News

Study Questions Role of BP Meds in Patients With Hypertension but No Other CVD Risk Factors

L.A. McKeown

October 30, 2018

News Daily News

Long-term Risk Factor Control Linked to Survival in COURAGE Substudy

Yael L. Maxwell

October 30, 2018

News Daily News

Benefit-Based Approach to Statins Pinpoints One in Six Patients Eligible for Therapy

Michael O'Riordan

October 25, 2018

News Daily News

Coronary CTA for Suspected CAD Shows Advantages in Predicting Hard Outcomes Over 10 Years

Yael L. Maxwell

October 23, 2018

News Daily News

Big Fitness Equals Big Survival Benefit, New Study Shows

Michael O'Riordan

October 22, 2018

News Daily News

More Research Supports Use of Aspirin Alone to Prevent VTE After Knee Replacement Surgery

L.A. McKeown

October 18, 2018

News Daily News

Statin Benefits: Yes for CVD but No for Everything Else, Says New Review

Michael O'Riordan

October 08, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2018

Shelley Wood

October 02, 2018

News Daily News

Prescription Omega-3 Fatty Acids Cut Cardiovascular Events: REDUCE-IT

Shelley Wood

September 24, 2018

News Daily News

Benefits of Dairy, Particularly Milk and Yogurt, Get Boost in New PURE Analysis

Michael O'Riordan

September 13, 2018

News Conference News ESC 2018

ASCOT Legacy: Calcium Channel Blockers, Statins Confer Long-term Survival Benefits in Hypertensive Patients

L.A. McKeown

August 31, 2018

News Conference News ESC 2018

Sobering News From Europe: CVD Risk Factors Are on the Rise or Holding Firm

Todd Neale

August 27, 2018

News Conference News ESC 2018

Omega-3 Fatty Acids Fail to Reduce CVD Events in Diabetic Patients: ASCEND

Michael O'Riordan

August 26, 2018

Advertisement

‘Accelerated Atherosclerosis’ Not Uncommon in Arteries of Young People

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

Sit Less, Move More: New Physical Activity Guidelines Stress Movement at All Ages

New Cholesterol Guidelines Make Room for Non-Statin Therapy and CAC Screening

ODYSSEY Outcomes Published as New Cholesterol Guidelines Loom

Statins Provide No Clinical Benefit When Coronary Calcium Is Zero, Study Shows

Study Questions Role of BP Meds in Patients With Hypertension but No Other CVD Risk Factors

Long-term Risk Factor Control Linked to Survival in COURAGE Substudy

Benefit-Based Approach to Statins Pinpoints One in Six Patients Eligible for Therapy

Coronary CTA for Suspected CAD Shows Advantages in Predicting Hard Outcomes Over 10 Years

Big Fitness Equals Big Survival Benefit, New Study Shows

More Research Supports Use of Aspirin Alone to Prevent VTE After Knee Replacement Surgery

Statin Benefits: Yes for CVD but No for Everything Else, Says New Review

TCTMD’s Top 10 Most Popular Stories for September 2018

Prescription Omega-3 Fatty Acids Cut Cardiovascular Events: REDUCE-IT

Benefits of Dairy, Particularly Milk and Yogurt, Get Boost in New PURE Analysis

ASCOT Legacy: Calcium Channel Blockers, Statins Confer Long-term Survival Benefits in Hypertensive Patients

Sobering News From Europe: CVD Risk Factors Are on the Rise or Holding Firm

Omega-3 Fatty Acids Fail to Reduce CVD Events in Diabetic Patients: ASCEND

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content